Results 101 to 110 of about 5,021,475 (359)

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Research in business ethics

open access: yesKoers : Bulletin for Christian Scholarship, 2001
Research in business ethics is vital for the expansion and credibility of this fairly recent academic field. This article argues that there are three factors that are crucially important for research in business ethics.
G.J. Rossouw
doaj   +1 more source

Well-Being Baseline Study Naskapi Nation of Kawawachikamach –March 2014 [PDF]

open access: yes
This study was modelled after Peter Siebenmorgan and Dr. Ben Bradshaw’s successful work in Northern Ontario. I would like to express my appreciation to the Naskapi Nation of Kawawachikamach, the band office, the development corporation, the McGill ...
Bradshaw, Ben   +3 more
core  

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Ethics in survey research

open access: yesJournal of the College of Community Physicians, 1999
No abstract ...
Malcolm A. Fernando
doaj   +1 more source

HREC members\u27 personal values influence decision making in contentious cases [PDF]

open access: yes, 2017
This article identifies 14 contentious issues faced by Human Research Ethics Committees (HRECs). The authors argue that HREC members will respond variably to these issues based on their own fundamental values and worldview. In particular, we propose that
Brewer, Keagan   +4 more
core   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

open access: yesMolecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard   +12 more
wiley   +1 more source

A Methodological Reflection on Converging Technologies and Their Relevance to Informa-tion Ethics [PDF]

open access: yes, 2010
In light of converging technologies, there is a clear sense that ethicists of various technological domains are coming together. Or, that they should come together. Yet, despite increasing cooperation and boundary-crossing in various fields of the ethics
Wong, Pak-Hang
core   +2 more sources

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

open access: yesMolecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang   +8 more
wiley   +1 more source

Big Data Ethics in Research [PDF]

open access: yes
The main problems faced by scientists in working with Big Data sets, highlighting the main ethical issues, taking into account the legislation of the European Union.
Sfetcu, Nicolae
core  

Home - About - Disclaimer - Privacy